Mavacamten will lower the extent or impact of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten might reduce systemic exposures of ethinyl estradiol and progestin, which can result in contraceptive failure or a rise in breakthrough https://garrettxnbpd.bloggadores.com/29716408/wymzya-fe-fundamentals-explained